Skip to content

Clinical trials

Insulin Resistance trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Country / region: South Korea Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20052
20072
20081
20096
20103
20118
20122
20142
20152
20172
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated2
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gachon University Gil Medical Center13
Seoul National University Hospital6
Eli Lilly and Company3
Seoul National University Bundang Hospital3
Yonsei University3
Samsung Medical Center2
Sanofi2
Chonbuk National University Hospital1
GlaxoSmithKline1
Korea University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance36
Diabetes Mellitus9
Diabetes Mellitus, Type 29
Hypercholesterolemia8
Hyperglycemia4
Hypertriglyceridemia4
Metabolic Diseases3
Hypertension2
Prediabetic State2
Atherosclerosis1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.